Global Retinal Vein Occlusion Market Research Report 2023

Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide.

The global Retinal Vein Occlusion market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.

This report aims to provide a comprehensive presentation of the global market for Retinal Vein Occlusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Vein Occlusion.

The Retinal Vein Occlusion market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Retinal Vein Occlusion market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Retinal Vein Occlusion companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Retinal Vein Occlusion Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Branch Retinal Artery Occlusion

1.2.3 Central Retinal Vein Occlusion

1.3 Market by Application

1.3.1 Global Retinal Vein Occlusion Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals and Clinics

1.3.3 Research and Academics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Retinal Vein Occlusion Market Perspective (2018-2029)

2.2 Retinal Vein Occlusion Growth Trends by Region

2.2.1 Global Retinal Vein Occlusion Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Retinal Vein Occlusion Historic Market Size by Region (2018-2023)

2.2.3 Retinal Vein Occlusion Forecasted Market Size by Region (2024-2029)

2.3 Retinal Vein Occlusion Market Dynamics

2.3.1 Retinal Vein Occlusion Industry Trends

2.3.2 Retinal Vein Occlusion Market Drivers

2.3.3 Retinal Vein Occlusion Market Challenges

2.3.4 Retinal Vein Occlusion Market Restraints

3.1 Global Top Retinal Vein Occlusion Players by Revenue

3.1.1 Global Top Retinal Vein Occlusion Players by Revenue (2018-2023)

3.1.2 Global Retinal Vein Occlusion Revenue Market Share by Players (2018-2023)

3.2 Global Retinal Vein Occlusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Retinal Vein Occlusion Revenue

3.4 Global Retinal Vein Occlusion Market Concentration Ratio

3.4.1 Global Retinal Vein Occlusion Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Retinal Vein Occlusion Revenue in 2022

3.5 Retinal Vein Occlusion Key Players Head office and Area Served

3.6 Key Players Retinal Vein Occlusion Product Solution and Service

3.7 Date of Enter into Retinal Vein Occlusion Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Retinal Vein Occlusion Historic Market Size by Type (2018-2023)

4.2 Global Retinal Vein Occlusion Forecasted Market Size by Type (2024-2029)

5.1 Global Retinal Vein Occlusion Historic Market Size by Application (2018-2023)

5.2 Global Retinal Vein Occlusion Forecasted Market Size by Application (2024-2029)

6.1 North America Retinal Vein Occlusion Market Size (2018-2029)

6.2 North America Retinal Vein Occlusion Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Retinal Vein Occlusion Market Size by Country (2018-2023)

6.4 North America Retinal Vein Occlusion Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Retinal Vein Occlusion Market Size (2018-2029)

7.2 Europe Retinal Vein Occlusion Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Retinal Vein Occlusion Market Size by Country (2018-2023)

7.4 Europe Retinal Vein Occlusion Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Retinal Vein Occlusion Market Size (2018-2029)

8.2 Asia-Pacific Retinal Vein Occlusion Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Retinal Vein Occlusion Market Size by Region (2018-2023)

8.4 Asia-Pacific Retinal Vein Occlusion Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Retinal Vein Occlusion Market Size (2018-2029)

9.2 Latin America Retinal Vein Occlusion Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Retinal Vein Occlusion Market Size by Country (2018-2023)

9.4 Latin America Retinal Vein Occlusion Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Retinal Vein Occlusion Market Size (2018-2029)

10.2 Middle East & Africa Retinal Vein Occlusion Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2018-2023)

10.4 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Retinal Vein Occlusion Introduction

11.1.4 Allergan Revenue in Retinal Vein Occlusion Business (2018-2023)

11.1.5 Allergan Recent Development

11.2 Bayer

11.2.1 Bayer Company Detail

11.2.2 Bayer Business Overview

11.2.3 Bayer Retinal Vein Occlusion Introduction

11.2.4 Bayer Revenue in Retinal Vein Occlusion Business (2018-2023)

11.2.5 Bayer Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Retinal Vein Occlusion Introduction

11.3.4 Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2018-2023)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Regeneron Pharmaceuticals

11.4.1 Regeneron Pharmaceuticals Company Detail

11.4.2 Regeneron Pharmaceuticals Business Overview

11.4.3 Regeneron Pharmaceuticals Retinal Vein Occlusion Introduction

11.4.4 Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2018-2023)

11.4.5 Regeneron Pharmaceuticals Recent Development

11.5 Ellex Medical Lasers

11.5.1 Ellex Medical Lasers Company Detail

11.5.2 Ellex Medical Lasers Business Overview

11.5.3 Ellex Medical Lasers Retinal Vein Occlusion Introduction

11.5.4 Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2018-2023)

11.5.5 Ellex Medical Lasers Recent Development

11.6 GlaxoSmithKline Plc.

11.6.1 GlaxoSmithKline Plc. Company Detail

11.6.2 GlaxoSmithKline Plc. Business Overview

11.6.3 GlaxoSmithKline Plc. Retinal Vein Occlusion Introduction

11.6.4 GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.6.5 GlaxoSmithKline Plc. Recent Development

11.7 IRIDEX Corporation

11.7.1 IRIDEX Corporation Company Detail

11.7.2 IRIDEX Corporation Business Overview

11.7.3 IRIDEX Corporation Retinal Vein Occlusion Introduction

11.7.4 IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2018-2023)

11.7.5 IRIDEX Corporation Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Retinal Vein Occlusion Introduction

11.8.4 Novartis Revenue in Retinal Vein Occlusion Business (2018-2023)

11.8.5 Novartis Recent Development

11.9 Quantel Medical Inc.

11.9.1 Quantel Medical Inc. Company Detail

11.9.2 Quantel Medical Inc. Business Overview

11.9.3 Quantel Medical Inc. Retinal Vein Occlusion Introduction

11.9.4 Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.9.5 Quantel Medical Inc. Recent Development

11.10 Topcon Medical Systems, Inc.

11.10.1 Topcon Medical Systems, Inc. Company Detail

11.10.2 Topcon Medical Systems, Inc. Business Overview

11.10.3 Topcon Medical Systems, Inc. Retinal Vein Occlusion Introduction

11.10.4 Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.10.5 Topcon Medical Systems, Inc. Recent Development

11.11 ZEISS

11.11.1 ZEISS Company Detail

11.11.2 ZEISS Business Overview

11.11.3 ZEISS Retinal Vein Occlusion Introduction

11.11.4 ZEISS Revenue in Retinal Vein Occlusion Business (2018-2023)

11.11.5 ZEISS Recent Development

11.12 Lumenis

11.12.1 Lumenis Company Detail

11.12.2 Lumenis Business Overview

11.12.3 Lumenis Retinal Vein Occlusion Introduction

11.12.4 Lumenis Revenue in Retinal Vein Occlusion Business (2018-2023)

11.12.5 Lumenis Recent Development

11.13 Sanofi Aventis

11.13.1 Sanofi Aventis Company Detail

11.13.2 Sanofi Aventis Business Overview

11.13.3 Sanofi Aventis Retinal Vein Occlusion Introduction

11.13.4 Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2018-2023)

11.13.5 Sanofi Aventis Recent Development

11.14 Bausch Health

11.14.1 Bausch Health Company Detail

11.14.2 Bausch Health Business Overview

11.14.3 Bausch Health Retinal Vein Occlusion Introduction

11.14.4 Bausch Health Revenue in Retinal Vein Occlusion Business (2018-2023)

11.14.5 Bausch Health Recent Development

11.15 Alimera Sciences

11.15.1 Alimera Sciences Company Detail

11.15.2 Alimera Sciences Business Overview

11.15.3 Alimera Sciences Retinal Vein Occlusion Introduction

11.15.4 Alimera Sciences Revenue in Retinal Vein Occlusion Business (2018-2023)

11.15.5 Alimera Sciences Recent Development

11.16 Fovea Pharmaceuticals SA

11.16.1 Fovea Pharmaceuticals SA Company Detail

11.16.2 Fovea Pharmaceuticals SA Business Overview

11.16.3 Fovea Pharmaceuticals SA Retinal Vein Occlusion Introduction

11.16.4 Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2018-2023)

11.16.5 Fovea Pharmaceuticals SA Recent Development

11.17 Icon Biosciences

11.17.1 Icon Biosciences Company Detail

11.17.2 Icon Biosciences Business Overview

11.17.3 Icon Biosciences Retinal Vein Occlusion Introduction

11.17.4 Icon Biosciences Revenue in Retinal Vein Occlusion Business (2018-2023)

11.17.5 Icon Biosciences Recent Development

11.18 Suzuken Co.Ltd.

11.18.1 Suzuken Co.Ltd. Company Detail

11.18.2 Suzuken Co.Ltd. Business Overview

11.18.3 Suzuken Co.Ltd. Retinal Vein Occlusion Introduction

11.18.4 Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.18.5 Suzuken Co.Ltd. Recent Development

11.19 Genentech, Inc.

11.19.1 Genentech, Inc. Company Detail

11.19.2 Genentech, Inc. Business Overview

11.19.3 Genentech, Inc. Retinal Vein Occlusion Introduction

11.19.4 Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.19.5 Genentech, Inc. Recent Development

11.20 Ranbaxy Pharmaceuticals

11.20.1 Ranbaxy Pharmaceuticals Company Detail

11.20.2 Ranbaxy Pharmaceuticals Business Overview

11.20.3 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Introduction

11.20.4 Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2018-2023)

11.20.5 Ranbaxy Pharmaceuticals Recent Development

11.21 Johnson & Johnson Services, Inc.

11.21.1 Johnson & Johnson Services, Inc. Company Detail

11.21.2 Johnson & Johnson Services, Inc. Business Overview

11.21.3 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Introduction

11.21.4 Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.21.5 Johnson & Johnson Services, Inc. Recent Development

11.22 Teva Pharmaceutical, Pfizer Inc.

11.22.1 Teva Pharmaceutical, Pfizer Inc. Company Detail

11.22.2 Teva Pharmaceutical, Pfizer Inc. Business Overview

11.22.3 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Introduction

11.22.4 Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.22.5 Teva Pharmaceutical, Pfizer Inc. Recent Development

11.23 Astrazeneca

11.23.1 Astrazeneca Company Detail

11.23.2 Astrazeneca Business Overview

11.23.3 Astrazeneca Retinal Vein Occlusion Introduction

11.23.4 Astrazeneca Revenue in Retinal Vein Occlusion Business (2018-2023)

11.23.5 Astrazeneca Recent Development

11.24 Aerpio Therapeutics Inc.

11.24.1 Aerpio Therapeutics Inc. Company Detail

11.24.2 Aerpio Therapeutics Inc. Business Overview

11.24.3 Aerpio Therapeutics Inc. Retinal Vein Occlusion Introduction

11.24.4 Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2018-2023)

11.24.5 Aerpio Therapeutics Inc. Recent Development

11.25 Annexin Pharmaceuticals AB

11.25.1 Annexin Pharmaceuticals AB Company Detail

11.25.2 Annexin Pharmaceuticals AB Business Overview

11.25.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Introduction

11.25.4 Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2018-2023)

11.25.5 Annexin Pharmaceuticals AB Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Retinal Vein Occlusion Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Branch Retinal Artery Occlusion

    Table 3. Key Players of Central Retinal Vein Occlusion

    Table 4. Global Retinal Vein Occlusion Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Retinal Vein Occlusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Retinal Vein Occlusion Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Retinal Vein Occlusion Market Share by Region (2018-2023)

    Table 8. Global Retinal Vein Occlusion Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Retinal Vein Occlusion Market Share by Region (2024-2029)

    Table 10. Retinal Vein Occlusion Market Trends

    Table 11. Retinal Vein Occlusion Market Drivers

    Table 12. Retinal Vein Occlusion Market Challenges

    Table 13. Retinal Vein Occlusion Market Restraints

    Table 14. Global Retinal Vein Occlusion Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Retinal Vein Occlusion Market Share by Players (2018-2023)

    Table 16. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Vein Occlusion as of 2022)

    Table 17. Ranking of Global Top Retinal Vein Occlusion Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Retinal Vein Occlusion Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Retinal Vein Occlusion Product Solution and Service

    Table 21. Date of Enter into Retinal Vein Occlusion Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Retinal Vein Occlusion Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Retinal Vein Occlusion Revenue Market Share by Type (2018-2023)

    Table 25. Global Retinal Vein Occlusion Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Retinal Vein Occlusion Revenue Market Share by Type (2024-2029)

    Table 27. Global Retinal Vein Occlusion Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Retinal Vein Occlusion Revenue Market Share by Application (2018-2023)

    Table 29. Global Retinal Vein Occlusion Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Retinal Vein Occlusion Revenue Market Share by Application (2024-2029)

    Table 31. North America Retinal Vein Occlusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Retinal Vein Occlusion Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Retinal Vein Occlusion Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Retinal Vein Occlusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Retinal Vein Occlusion Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Retinal Vein Occlusion Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Retinal Vein Occlusion Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Retinal Vein Occlusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Retinal Vein Occlusion Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Retinal Vein Occlusion Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Retinal Vein Occlusion Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Allergan Company Detail

    Table 47. Allergan Business Overview

    Table 48. Allergan Retinal Vein Occlusion Product

    Table 49. Allergan Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 50. Allergan Recent Development

    Table 51. Bayer Company Detail

    Table 52. Bayer Business Overview

    Table 53. Bayer Retinal Vein Occlusion Product

    Table 54. Bayer Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 55. Bayer Recent Development

    Table 56. Bristol-Myers Squibb Company Detail

    Table 57. Bristol-Myers Squibb Business Overview

    Table 58. Bristol-Myers Squibb Retinal Vein Occlusion Product

    Table 59. Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 60. Bristol-Myers Squibb Recent Development

    Table 61. Regeneron Pharmaceuticals Company Detail

    Table 62. Regeneron Pharmaceuticals Business Overview

    Table 63. Regeneron Pharmaceuticals Retinal Vein Occlusion Product

    Table 64. Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 65. Regeneron Pharmaceuticals Recent Development

    Table 66. Ellex Medical Lasers Company Detail

    Table 67. Ellex Medical Lasers Business Overview

    Table 68. Ellex Medical Lasers Retinal Vein Occlusion Product

    Table 69. Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 70. Ellex Medical Lasers Recent Development

    Table 71. GlaxoSmithKline Plc. Company Detail

    Table 72. GlaxoSmithKline Plc. Business Overview

    Table 73. GlaxoSmithKline Plc. Retinal Vein Occlusion Product

    Table 74. GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 75. GlaxoSmithKline Plc. Recent Development

    Table 76. IRIDEX Corporation Company Detail

    Table 77. IRIDEX Corporation Business Overview

    Table 78. IRIDEX Corporation Retinal Vein Occlusion Product

    Table 79. IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 80. IRIDEX Corporation Recent Development

    Table 81. Novartis Company Detail

    Table 82. Novartis Business Overview

    Table 83. Novartis Retinal Vein Occlusion Product

    Table 84. Novartis Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 85. Novartis Recent Development

    Table 86. Quantel Medical Inc. Company Detail

    Table 87. Quantel Medical Inc. Business Overview

    Table 88. Quantel Medical Inc. Retinal Vein Occlusion Product

    Table 89. Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 90. Quantel Medical Inc. Recent Development

    Table 91. Topcon Medical Systems, Inc. Company Detail

    Table 92. Topcon Medical Systems, Inc. Business Overview

    Table 93. Topcon Medical Systems, Inc. Retinal Vein Occlusion Product

    Table 94. Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 95. Topcon Medical Systems, Inc. Recent Development

    Table 96. ZEISS Company Detail

    Table 97. ZEISS Business Overview

    Table 98. ZEISS Retinal Vein Occlusion Product

    Table 99. ZEISS Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 100. ZEISS Recent Development

    Table 101. Lumenis Company Detail

    Table 102. Lumenis Business Overview

    Table 103. Lumenis Retinal Vein Occlusion Product

    Table 104. Lumenis Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 105. Lumenis Recent Development

    Table 106. Sanofi Aventis Company Detail

    Table 107. Sanofi Aventis Business Overview

    Table 108. Sanofi Aventis Retinal Vein Occlusion Product

    Table 109. Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 110. Sanofi Aventis Recent Development

    Table 111. Bausch Health Company Detail

    Table 112. Bausch Health Business Overview

    Table 113. Bausch Health Retinal Vein Occlusion Product

    Table 114. Bausch Health Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 115. Bausch Health Recent Development

    Table 116. Alimera Sciences Company Detail

    Table 117. Alimera Sciences Business Overview

    Table 118. Alimera Sciences Retinal Vein Occlusion Product

    Table 119. Alimera Sciences Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 120. Alimera Sciences Recent Development

    Table 121. Fovea Pharmaceuticals SA Company Detail

    Table 122. Fovea Pharmaceuticals SA Business Overview

    Table 123. Fovea Pharmaceuticals SA Retinal Vein Occlusion Product

    Table 124. Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 125. Fovea Pharmaceuticals SA Recent Development

    Table 126. Icon Biosciences Company Detail

    Table 127. Icon Biosciences Business Overview

    Table 128. Icon Biosciences Retinal Vein Occlusion Product

    Table 129. Icon Biosciences Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 130. Icon Biosciences Recent Development

    Table 131. Suzuken Co.Ltd. Company Detail

    Table 132. Suzuken Co.Ltd. Business Overview

    Table 133. Suzuken Co.Ltd. Retinal Vein Occlusion Product

    Table 134. Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 135. Suzuken Co.Ltd. Recent Development

    Table 136. Genentech, Inc. Company Detail

    Table 137. Genentech, Inc. Business Overview

    Table 138. Genentech, Inc. Retinal Vein Occlusion Product

    Table 139. Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 140. Genentech, Inc. Recent Development

    Table 141. Ranbaxy Pharmaceuticals Company Detail

    Table 142. Ranbaxy Pharmaceuticals Business Overview

    Table 143. Ranbaxy Pharmaceuticals Retinal Vein Occlusion Product

    Table 144. Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 145. Ranbaxy Pharmaceuticals Recent Development

    Table 146. Johnson & Johnson Services, Inc. Company Detail

    Table 147. Johnson & Johnson Services, Inc. Business Overview

    Table 148. Johnson & Johnson Services, Inc. Retinal Vein Occlusion Product

    Table 149. Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 150. Johnson & Johnson Services, Inc. Recent Development

    Table 151. Teva Pharmaceutical, Pfizer Inc. Company Detail

    Table 152. Teva Pharmaceutical, Pfizer Inc. Business Overview

    Table 153. Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Product

    Table 154. Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 155. Teva Pharmaceutical, Pfizer Inc. Recent Development

    Table 156. Astrazeneca Company Detail

    Table 157. Astrazeneca Business Overview

    Table 158. Astrazeneca Retinal Vein Occlusion Product

    Table 159. Astrazeneca Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 160. Astrazeneca Recent Development

    Table 161. Aerpio Therapeutics Inc. Company Detail

    Table 162. Aerpio Therapeutics Inc. Business Overview

    Table 163. Aerpio Therapeutics Inc. Retinal Vein Occlusion Product

    Table 164. Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 165. Aerpio Therapeutics Inc. Recent Development

    Table 166. Annexin Pharmaceuticals AB Company Detail

    Table 167. Annexin Pharmaceuticals AB Business Overview

    Table 168. Annexin Pharmaceuticals AB Retinal Vein Occlusion Product

    Table 169. Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2018-2023) & (US$ Million)

    Table 170. Annexin Pharmaceuticals AB Recent Development

    Table 171. Research Programs/Design for This Report

    Table 172. Key Data Information from Secondary Sources

    Table 173. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Retinal Vein Occlusion Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Retinal Vein Occlusion Market Share by Type: 2022 VS 2029

    Figure 3. Branch Retinal Artery Occlusion Features

    Figure 4. Central Retinal Vein Occlusion Features

    Figure 5. Global Retinal Vein Occlusion Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Retinal Vein Occlusion Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals and Clinics Case Studies

    Figure 8. Research and Academics Case Studies

    Figure 9. Others Case Studies

    Figure 10. Retinal Vein Occlusion Report Years Considered

    Figure 11. Global Retinal Vein Occlusion Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Retinal Vein Occlusion Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Retinal Vein Occlusion Market Share by Region: 2022 VS 2029

    Figure 14. Global Retinal Vein Occlusion Market Share by Players in 2022

    Figure 15. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Vein Occlusion as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Retinal Vein Occlusion Revenue in 2022

    Figure 17. North America Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Retinal Vein Occlusion Market Share by Country (2018-2029)

    Figure 19. United States Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Retinal Vein Occlusion Market Share by Country (2018-2029)

    Figure 23. Germany Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Retinal Vein Occlusion Market Share by Region (2018-2029)

    Figure 31. China Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Retinal Vein Occlusion Market Share by Country (2018-2029)

    Figure 39. Mexico Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Retinal Vein Occlusion Market Share by Country (2018-2029)

    Figure 43. Turkey Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Retinal Vein Occlusion Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Allergan Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 46. Bayer Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 48. Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 49. Ellex Medical Lasers Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 50. GlaxoSmithKline Plc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 51. IRIDEX Corporation Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 52. Novartis Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 53. Quantel Medical Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 54. Topcon Medical Systems, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 55. ZEISS Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 56. Lumenis Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 57. Sanofi Aventis Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 58. Bausch Health Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 59. Alimera Sciences Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 60. Fovea Pharmaceuticals SA Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 61. Icon Biosciences Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 62. Suzuken Co.Ltd. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 63. Genentech, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 64. Ranbaxy Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 65. Johnson & Johnson Services, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 66. Teva Pharmaceutical, Pfizer Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 67. Astrazeneca Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 68. Aerpio Therapeutics Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 69. Annexin Pharmaceuticals AB Revenue Growth Rate in Retinal Vein Occlusion Business (2018-2023)

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed